Infinity Pharmaceuticals, Inc.

Infinity Pharmaceuticals, Inc.verified

INFI

Price:

$0.008

Market Cap:

$726.09K

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, ...[Read more]

Industry

Biotechnology

IPO Date

2000-07-28

Stock Exchange

NASDAQ

Ticker

INFI

The PE Ratio as of May 2024 (TTM) for Infinity Pharmaceuticals, Inc. (INFI) is -0.02

According to Infinity Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -98.47% compared to the average of -1.19 of the last 4 quarters.

Infinity Pharmaceuticals, Inc. (INFI) Historical PE Ratio (quarterly & annually)

How has INFI PE Ratio performed in the past?

The mean historical PE Ratio of Infinity Pharmaceuticals, Inc. over the last ten years is -7.53. The current -0.02 PE Ratio has changed -75.86% with respect to the historical average. Over the past ten years (40 quarters), INFI's PE Ratio was at its highest in in the September 2018 quarter at 2.77. The PE Ratio was at its lowest in in the September 2021 quarter at -7.08.

Quarterly (TTM)
Annual

Average

-7.53

Median

-2.98

Minimum

-47.09

Maximum

-1.16

Infinity Pharmaceuticals, Inc. (INFI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Infinity Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 801.92%

Maximum Annual PE Ratio = -1.16

Minimum Annual Increase = -93.63%

Minimum Annual PE Ratio = -47.09

Quarterly (TTM)
Annual
YearPE RatioChange
2022-1.16-72.74%
2021-4.2443.40%
2020-2.96154.23%
2019-1.16-79.99%
2018-5.81136.81%
2017-2.4510.28%
2016-2.22-25.87%
2015-3.00-93.63%
2014-47.09801.92%
2013-5.22-74.61%

Infinity Pharmaceuticals, Inc. (INFI) Average PE Ratio

How has INFI PE Ratio performed in the past?

The current PE Ratio of Infinity Pharmaceuticals, Inc. (INFI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-2.78

5-year avg

-3.06

10-year avg

-7.53

Infinity Pharmaceuticals, Inc. (INFI) PE Ratio vs. Peers

How is INFI’s PE Ratio compared to its peers?

Infinity Pharmaceuticals, Inc.’s PE Ratio is greater than NextCure, Inc. (-0.68), greater than Chimerix, Inc. (-1.01), greater than Eledon Pharmaceuticals, Inc. (-2.12), greater than Kiromic BioPharma, Inc. (-0.19), greater than Neoleukin Therapeutics, Inc. (-0.98), less than CytomX Therapeutics, Inc. (8.68), greater than Assembly Biosciences, Inc. (-1.61), greater than Instil Bio, Inc. (-0.58), greater than Nuvation Bio Inc. (-9.80), greater than Generation Bio Co. (-1.21), greater than Kronos Bio, Inc. (-0.39), greater than Erasca, Inc. (-3.13), greater than C4 Therapeutics, Inc. (-2.97), greater than Edgewise Therapeutics, Inc. (-14.15), greater than Lyra Therapeutics, Inc. (-0.30), greater than Trevi Therapeutics, Inc. (-7.41), greater than SQZ Biotechnologies Company (-3.78), greater than Protara Therapeutics, Inc. (-0.75), less than TRACON Pharmaceuticals, Inc. (2.04), greater than Aditxt, Inc. (-0.08), greater than NeuroBo Pharmaceuticals, Inc. (-1.27), greater than Dermata Therapeutics, Inc. (-0.17), greater than Unicycive Therapeutics, Inc. (-0.89), greater than Revelation Biosciences, Inc. (-0.22),

Build a custom stock screener for Infinity Pharmaceuticals, Inc. (INFI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Infinity Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Infinity Pharmaceuticals, Inc. (INFI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Infinity Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Infinity Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Infinity Pharmaceuticals, Inc. (INFI)?

What is the highest PE Ratio for Infinity Pharmaceuticals, Inc. (INFI)?

What is the 3-year average PE Ratio for Infinity Pharmaceuticals, Inc. (INFI)?

What is the 5-year average PE Ratio for Infinity Pharmaceuticals, Inc. (INFI)?

How does the current PE Ratio for Infinity Pharmaceuticals, Inc. (INFI) compare to its historical average?